SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-18-015600
Filing Date
2018-11-14
Accepted
2018-11-14 06:26:17
Documents
1
Group Members
EN FIDECOMISO DE MI VIDA 11/23/2010 (TRUST)

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d1118johnson_adialpharma.htm SC 13D 97720
  Complete submission text file 0001213900-18-015600.txt   99284
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Subject) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90718 | Film No.: 181180247
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address
Johnson Bankole A. (Filed by) CIK: 0001718158 (see all company filings)

Type: SC 13D